Greg Hather

754 citations

22 papers · 547 indexed · h-index 11

Impact in

Genetics
- Inflammatory Bowel Disease
Epidemiology
- Microscopic Colitis

Papers in ⓘ

Modeling and Simulation 2
Infectious Diseases 5
- Viral Infections and Vectors 3

Co-authors: Mary C. Wildermuth (2 shared papers)Divya Chandran (2 shared papers)Noriko Inada (1 shared paper)Javaria Mona Khalid (5 shared papers)Dirk Demuth (5 shared papers)Axel Dignaß (5 shared papers)Edward V. Loftus (5 shared papers)Laurent Peyrin‐Biroulet (5 shared papers)
Journals: Journal of Crohn s and Colitis (2 papers)Clinical and Translational Science (2 papers)PLoS ONE (2 papers)Gastroenterology (2 papers)Molecular Cancer Therapeutics (1 paper)
Partner nations: United States United Kingdom Germany

In The Last Decade

Greg Hather

21 papers receiving 540 citations

Peers

Countries citing papers authored by Greg Hather

Since Specialization

Citations

This map shows the geographic impact of Greg Hather's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Hather with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Hather more than expected).

Fields of papers citing papers by Greg Hather

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Greg Hather. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Hather. The network helps show where Greg Hather may publish in the future.

Co-authors

The 25 scholars most cited alongside Greg Hather, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Greg Hather Line = papers co-authored together Greg Hather links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Laser microdissection of Arabidopsis cells at the powdery mildew infection site reveals site-specific processes and regulators Proceedings of the National Academy of Sciences ·Divya Chandran, Noriko Inada, Greg Hather, Christiane Katja Kleindt, Mary C. Wildermuth	2009	148
2	Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease Journal of Gastroenterology ·Stefan Schreiber, Axel Dignaß, Laurent Peyrin‐Biroulet, Greg Hather, Dirk Demuth, Mahmoud Mosli, Rebecca Curtis, Javaria Mona Khalid, Edward V. Loftus	2018	115
3	Novel DNA Damage Checkpoints Mediating Cell Death Induced by the NEDD8-Activating Enzyme Inhibitor MLN4924 Cancer Research ·Jonathan L. Blank, Xiaozhen J. Liu, Katherine Cosmopoulos, David C. Bouck, Khristofer Garcia, Hugues Bernard, Olga Tayber, Greg Hather, Ray Liu, Usha Narayanan, Michael A. Milhollen, Eric S. Lightcap	2012	85
4	Nedd8-Activating Enzyme Inhibitor MLN4924 Provides Synergy with Mitomycin C through Interactions with ATR, BRCA1/BRCA2, and Chromatin Dynamics Pathways Molecular Cancer Therapeutics ·Khristofer Garcia, Jonathan L. Blank, David C. Bouck, Xiaozhen J. Liu, Darshan S. Sappal, Greg Hather, Katherine Cosmopoulos, Michael P. Thomas, Mike Kuranda, Michael D. Pickard, Ray Liu, Syamala Bandi, Peter G. Smith, Eric S. Lightcap	2014	45
5	Continuous Monitoring Using a Wearable Device Detects Activity‐Induced Heart Rate Changes After Administration of Amphetamine Clinical and Translational Science ·Elena S. Izmailova, Lachy McLean, Greg Hather, David Merberg, Jason Homsy, Matthew Cantor, Dmitri Volfson, Gaurav Bhatia, Eric Perakslis, Christopher Benko, John A. Wagner	2019	29
6	Evaluation of Wearable Digital Devices in a Phase I Clinical Trial Clinical and Translational Science ·Elena S. Izmailova, Lachy McLean, Gaurav Bhatia, Greg Hather, Matthew Cantor, David Merberg, Eric Perakslis, Christopher Benko, John A. Wagner	2019	27
7	Complete Protection in Macaques Conferred by Purified Inactivated Zika Vaccine: Defining a Correlate of Protection Scientific Reports ·Ginger Young, Kelly J. Bohning, Melissa Zahralban-Steele, Greg Hather, Sambasivarao Tadepalli, Kristen Mickey, C. Godin, Srisowmya Sanisetty, Stephanie Sonnberg, Hetal Patel, Hansi Dean	2020	20
8	Efficacy of biologic therapies for biologic-naïve Japanese patients with moderately to severely active ulcerative colitis: a network meta-analysis Intestinal Research ·Toshifumi Hibi∥, Isao Kamae, Philippe Pinton, Lyann Ursos, Ryuichi Iwakiri, Greg Hather, Haridarshan Patel	2020	15
9	KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism PLoS ONE ·Nibedita Chattopadhyay, Allison Berger, Erik Koenig, Bret Bannerman, James Garnsey, Hugues Bernard, Paul Hales, Angel Maldonado Lopez, Yang Yu, Jill Donelan, Kristen G. Jordan, Stephen Tirrell, Bradley Stringer, Cindy Q. Xia, Greg Hather, Katherine Galvin, Mark Manfredi, Nelson Rhodes, Ben Amidon	2015	14
10	A high throughput reporter virus particle microneutralization assay for quantitation of Zika virus neutralizing antibodies in multiple species PLoS ONE ·Kelly Bohning, Stephanie Sonnberg, Hui‐Ling Chen, Melissa Zahralban-Steele, Powell Timothy., Greg Hather, Hetal Patel, Hansi Dean	2021	11
11	Efficient Drug-Pathway Association Analysis via Integrative Penalized Matrix Decomposition IEEE/ACM Transactions on Computational Biology and Bioinformatics ·Cong Li, Can Yang, Greg Hather, Ray Liu, Hongyu Zhao	2015	10
12	Specificity and Breadth of the Neutralizing Antibody Response to a Live-Attenuated Tetravalent Dengue Vaccine The Journal of Infectious Diseases ·Christina R. DeMaso, Lovkesh Karwal, Melissa Zahralban-Steele, David Ernesto Marón Domínguez, Zhang-Li Springer, Maima Kaiser, Sunil Palani, Tim Rindfleisch, Kelly Bohning, Greg Hather, Subash C. Das, Mayuri Sharma, Hansi Dean	2022	8
13	Predicting Outcomes in Patients With Diffuse Large B-Cell Lymphoma Treated With Standard of Care Cancer Informatics ·Aaron Galaznik, Christian Reich, Greg Klebanov, Yuriy Khoma, Eldar Allakhverdiiev, Greg Hather, Yaping Shou	2019	4
14	P305 Indirect comparison of two novel biologics for the treatment of Crohn's disease : network-meta analysis of ustekinumab vs vedolizumab Journal of Crohn s and Colitis ·Greg Hather, Rebecca Curtis, K. Minda, Ismail Azzabi Zouraq, Javaria Mona Khalid	2017	4
15	Using mixed-effects modeling to estimate decay kinetics of response to SARS-CoV-2 infection PubMed ·Dean Bottino, Greg Hather, Lin Yuan, Madison Stoddard, Lin White, Arijit Chakravarty	2021	3
16	Heterogeneity in Vaccinal Immunity to SARS-CoV-2 Can Be Addressed by a Personalized Booster Strategy Vaccines ·Madison Stoddard, Lin Yuan, Sharanya Sarkar, Shruthi Mangalaganesh, Ryan P. Nolan, Dean Bottino, Greg Hather, Natasha S. Hochberg, Laura F. White, Arijit Chakravarty	2023	2
17	Global Expression Profiling of RNA from Laser Microdissected Cells at Fungal–Plant Interaction Sites Methods in molecular biology ·Divya Chandran, Greg Hather, Mary C. Wildermuth	2011	2
18	Real World Effectiveness of Vedolizumab Over One Year in Inflammatory Bowel Disease: A Meta-Analysis Gastroenterology ·Stefan Schreiber, Axel Dignaß, Laurent Peyrin‐Biroulet, Greg Hather, Dirk Demuth, Javaria Mona Khalid, Edward V. Loftus	2017	2
19	Predicting Efficacy of a Purified Inactivated Zika Virus Vaccine in Flavivirus-Naïve Humans Using an Immunological Correlate of Protection in Non-Human Primates Microorganisms ·Camilo J. Acosta, Francesco Nordio, David A. Boltz, Whitney R. Baldwin, Greg Hather, Eloi Kpamegan	2024	1
20	P155 REAL-WORLD SAFETY OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A META-ANALYSIS Inflammatory Bowel Diseases ·Stefan Schreiber, Axel Dignaß, Laurent Peyrin‐Biroulet, Mahmoud Mosli, Greg Hather, Dirk Demuth, Aimee Blake, Rebecca Curtis, Javaria Mona Khalid, Edward V. Loftus	2018	1

About Greg Hather

Greg Hather is a scholar working on Modeling and Simulation, Infectious Diseases, Genetics, Applied Psychology and Gastroenterology, having authored 22 papers that have together received 547 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (7 papers), Microscopic Colitis (5 papers), Mosquito-borne diseases and control (4 papers), Biosimilars and Bioanalytical Methods (3 papers), Malaria Research and Control (3 papers), Eosinophilic Esophagitis (3 papers), Ubiquitin and proteasome pathways (3 papers) and Viral Infections and Vectors (3 papers). The work is most often cited by research in Genetics (133 citations), Epidemiology (139 citations), Plant Science (137 citations), Cell Biology (54 citations) and Family Practice (7 citations). Greg Hather has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Mary C. Wildermuth, Divya Chandran, Noriko Inada, Javaria Mona Khalid, Dirk Demuth, Axel Dignaß, Edward V. Loftus, Laurent Peyrin‐Biroulet, Mahmoud Mosli and Stefan Schreiber. Their work appears in journals such as Journal of Crohn s and Colitis, Clinical and Translational Science, PLoS ONE, Gastroenterology and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact